Development of an oral treatment with the PPAR-γ-acting cannabinoid VCE-003.2 against the inflammation-driven neuronal deterioration in experimental Parkinson’s disease

  1. Burgaz, S.
  2. García, C.
  3. Gómez-Cañas, M.
  4. Muñoz, E.
  5. Fernández-Ruiz, J.
Aldizkaria:
Molecules

ISSN: 1420-3049

Argitalpen urtea: 2019

Alea: 24

Zenbakia: 15

Mota: Artikulua

DOI: 10.3390/MOLECULES24152702 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus